На главную
Видео добавленное пользователем “Specialty Pharmacy Times”
Inventor of Sofosbuvir Discusses Limited Patient Access to Drug
 
03:16
Michael Sofia, PhD, the inventor of the groundbreaking hepatitis C drug sofosbuvir, discusses the difficulties patients have had in accessing the revolutionary treatment.
Просмотров: 3115 Specialty Pharmacy Times
Treating RA with Methotrexate
 
05:55
Stanley B. Cohen, MD, details the roles of both oral and subcutaneous methotrexate in the treatment of rheumatoid arthritis.
Просмотров: 583 Specialty Pharmacy Times
Is There Value to Specialty Pharmacy Accreditation?
 
03:52
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss the ramifications of accreditation for a specialty pharmacy. Even though accreditation is not mandatory, Allen pointed out that it may be tacitly required in a way, since payor networks and pharmaceutical manufacturers use accreditation to make decisions about specialty pharmacies. Accrediting bodies such as the Utilization Review Accreditation Committee (URAC) review all aspects of an organization’s policies and procedures, from human resources to disaster planning. The panelists agreed that accreditation can benefit specialty pharmacies by instituting consistent monitoring of quality parameters. *The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc.
Просмотров: 592 Specialty Pharmacy Times
Hepatitis C Patient Journey: Coping With Drug Side Effects
 
02:58
In part four, Jim Wilson, RPh, MBA, president of WilsonRx, discusses the difficulties he faced during treatment from interferon therapy following his liver transplant. Wilson was infected with an acute case of Non-A/Non-B hepatitis in 1975 due to a tainted blood supply but was not diagnosed with the disease until 1999. After receiving a liver transplant in 2006, he was finally cured of HCV in 2012 after enrolling in a 12-week clinical trial of the drug Harvoni.
Просмотров: 1249 Specialty Pharmacy Times
Value of Specialty Pharmacy in Oncology
 
07:09
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss the value that specialty pharmacies can bring to the field of oncology. Of all of the drugs that have been approved in the past 2 years, 22 of them have been for oncology. In the past, many oncology medications were infused in the provider’s office, but now that so many novel oncology drugs are oral, the touch point has shifted from the provider to the specialty pharmacy, according to Allen. The panelists agreed that specialty pharmacies can provide value in the oncology space by utilizing proactive side effect mitigation strategies, such as side effect management kits and tip cards that patients and providers can refer to. Specialty pharmacies can function as a liaison to coordinate communication between the patient and the provider, Ness said. As more of these new oncology drugs are approved, Allen noted, the benefit investigation conducted by the specialty pharmacy will have a great impact on the patient experience. Rayberg said that providers and patients are excited by the new drugs and new mechanisms of action, but payors have the burden of understanding all of the new options and combinations while keeping use on label when possible. *The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc.
Просмотров: 1334 Specialty Pharmacy Times
Leiomyosarcoma Patient Discusses Treatment Roadmap, Challenges
 
03:43
Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.
Просмотров: 384 Specialty Pharmacy Times
It's Not 'Just A Uterine Fibroid'
 
02:14
Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma.
Просмотров: 399 Specialty Pharmacy Times
Optimizing the Specialty Drug Pathway from Manufacturers to Pharmacies
 
03:12
Cheryl Allen, RPh, BSPharm, MBA, discusses how relationships can be improved between manufacturers, pharmacy benefit managers, and pharmacies.
Просмотров: 260 Specialty Pharmacy Times
How Specialty Pharmacies Can Gain Access to Limited Distribution Drugs
 
02:59
Cheryl Allen, vice president of Industry Relations at Diplomat, discusses how specialty pharmacies can best position themselves to access limited distribution drugs.
Просмотров: 327 Specialty Pharmacy Times
Data Aggregation in Specialty Pharmacy
 
04:34
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss the various types of data collected by specialty pharmacies and of interest to payors. According to Allen, manufacturers and payors are looking for more longitudinal data from specialty pharmacies, including the patient’s history of previous therapies and concomitant therapies to layer more information together beyond the diagnosis. Ness mentioned the growing importance of third-party information technology solutions that can help organizations capture comprehensive data in a usable manner. In the limited distribution environment, Tancredi said that there is a call for data analytics such as utilization reports, patient status reports, and inventory reports. The data collected by specialty pharmacies may never become public, but as noted by Karalis, they will see more requests by payors, patients, and providers for data such as side effects and discontinuation rates. *The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc.
Просмотров: 495 Specialty Pharmacy Times
Rheumatoid Arthritis (RA): More Than a Disease of the Joints
 
35:20
Kevin Mange, MD, MSCE, head of North America Medical Immunology at Sanofi, provides a comprehensive overview of the considerations in the treatment of rheumatoid arthritis, which carries comorbidities that affect multiple organ systems.
Просмотров: 1668 Specialty Pharmacy Times
Challenges Ahead for Independent Specialty Pharmacies
 
01:19
Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the largest challenges currently facing independent specialty pharmacies.
Просмотров: 334 Specialty Pharmacy Times
The Future of Atopic Dermatitis
 
04:58
Panelists Peter L. Salgo, MD; Cheryl Allen, BS Pharm, MBA; Jeffrey D. Dunn, Pharm D, MBA; Ed Pezalla, MD, MPH; and Jonathan Silverberg, MD, PhD, MPH, outline the future of atopic dermatitis and provide final thoughts on the management of the disease.
Просмотров: 249 Specialty Pharmacy Times
Use of Biologics in Rheumatoid Arthritis
 
03:10
Stanley B. Cohen, MD, describes the use of biologics to treat rheumatoid arthritis.
Просмотров: 192 Specialty Pharmacy Times
Episode 6: Evaluating Specialty Pharmacy: Reliable Methods to Measure Quality
 
07:04
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss the various ways that quality of services can be measured within specialty pharmacies. The quality of the services provided by a specialty pharmacy can add value to the pharmaceutical manufacturer, because the representation of the pharmacy to its patients and providers can either reinforce the manufacturer’s brand or have a negative impact on the business, according to Tancredi. There are numerous methods of measuring quality. The panel described outcome measures such as time to therapy, time to fill prescriptions, duration that the patient is on therapy, converting scripts to filled prescriptions, persistency on therapy, access to payor networks, patient outreach capabilities, and the specialty pharmacy’s core offerings. For future improvements, accurate and thorough documentation will be key to determining quality outcomes at the patient level, Karalis said. When data is aggregated, individual rationales for actions, such as titrating up or down or interrupting a dose, may get lost. As a result, Allen noted the importance of designing a data set that provides actionable data to show what is happening in that specific patient’s journey. *The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc.
Просмотров: 679 Specialty Pharmacy Times
What Impact Does DIR Fees Have on Specialty Pharmacies?
 
02:01
Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the impact of direct and indirect remuneration (DIR) fees.
Просмотров: 144 Specialty Pharmacy Times
RA Treatment Guidelines
 
03:51
Stanley B. Cohen, MD, outlines the current treatment guidelines for rheumatoid arthritis and how they are followed in clinical practice.
Просмотров: 191 Specialty Pharmacy Times
Why Are Pharmacy Residency Programs Important?
 
01:24
Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses the importance of pharmacy residency programs.
Просмотров: 133 Specialty Pharmacy Times
How Do Biosimilars Differ from Generics?
 
01:27
Ron Lanton III, Esq., President, True North Political Solutions, discusses the significant differences between biosimilars and generic drugs.
Просмотров: 147 Specialty Pharmacy Times
Pharmacy Times and Specialty Pharmacy Times Bring You #APharmacistIs
 
01:27
As a part of the continuing effort to increase awareness and celebrate the pharmacy profession, Pharmacy Times and Specialty Pharmacy Times are partnering to launch the #APharmacistIs campaign. The goal is to educate patients and other healthcare professionals that pharmacists are more than just people who dispense medication. Please submit your photos using #APharamcistIs on social media and email submissions can be made to Laurie Toich (ltoich@specialtypharmacytimes).
Просмотров: 170 Specialty Pharmacy Times
How SmartPill Bottles Can Improve Medication Adherence
 
01:15
Josh Stein, CEO and Co-founder of AdhereTech, discusses how smart pill technology can improve adherence in patients on a specialty drug regimen.
Просмотров: 926 Specialty Pharmacy Times
Future Treatments for RA
 
03:32
Stanley B. Cohen, MD, discusses the future treatment options for rheumatoid arthritis.
Просмотров: 170 Specialty Pharmacy Times
What Makes URAC Accreditation Standards Unique?
 
01:48
Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses URAC specialty practice standards.
Просмотров: 450 Specialty Pharmacy Times
Sofosbuvir Inventor Discusses Impact of Discovering HCV Cure
 
01:32
Michael Sofia, PhD, the inventor of the groundbreaking hepatitis C drug sofosbuvir (Sovaldi), discusses the personal impact from curing hundreds of thousands of hepatitis C patients.
Просмотров: 467 Specialty Pharmacy Times
What's Next in the Hepatitis C Drug Pipeline
 
01:55
Janice Wahl, MD, Executive Director of Infections Diseases at Merck Research Laboratories, discusses the latest developments in hepatitis C treatment at Merck.
Просмотров: 270 Specialty Pharmacy Times
Staying on Top of Specialty Pharmacy Trends
 
00:59
Rinku Patel, PharmD, RPh, founder and CEO of KloudScript, discusses the latest trends in the specialty pharmacy landscape.
Просмотров: 87 Specialty Pharmacy Times
How Can PBM-Owned Specialty Pharmacies Threaten Independents?
 
01:41
Jesse C. Dresser, JD, Partner, Frier & Levitt, LLC, speaks about pharmacy benefit manager-owned specialty pharmacies and how they can impact independent specialty pharmacies.
Просмотров: 102 Specialty Pharmacy Times
What Steps Need to be Taken to Combat DIR Fees?
 
01:28
Ron Lanton III, Esq, president, True North Political Solutions, LLC, takes a legal perspective on direct and indirect remuneration fees and how they affect specialty pharmacies.
Просмотров: 88 Specialty Pharmacy Times
Oral Versus IV Oncolytics
 
04:28
Peter L. Salgo, MD; Carl T. Henningson, MD; Noa Biran, MD; Steven L. D’Amato, RPh, BSPharm; and Arturo Loaiza-Bonilla, MD, MSEd, FACP, review the differences between oral and intravenous therapy for treating cancer, including patient considerations.
Просмотров: 149 Specialty Pharmacy Times
Specialty Pharmacies Dispensing Oral Oncolytics
 
05:29
Peter L. Salgo, MD; Steven L. D’Amato, RPh, BSPharm; Arturo Loaiza-Bonilla, MD, MSEd, FACP; Noa Biran, MD; and Carl T. Henningson, MD, remark on the role of specialty pharmacies in dispensing oral oncolytics.
Просмотров: 77 Specialty Pharmacy Times
How Do We Know Specialty Pharmacies Are Providing Good Customer Service?
 
08:10
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss the services specialty pharmacies provide patients and how their performance can be measured. Before delving into specific performance measures, Allen described a typical patient experience with a specialty pharmacy, and Karalis explained how specialty pharmacies can enhance the patient experience by performing a thorough benefits investigation. A variety of performance metrics exist that can help ensure patients are receiving good service from their specialty pharmacies. According to Karalis, some of the patient touch points themselves can function as performance metrics, asking if their experience has been a positive one. In addition, first fill persistency rates and medication possession ratios can be used to assess performance as well. Ness added that patient-reported outcomes, starting with setting specific goals from the start, can help set expectations and assess outcomes. Turnaround time is another measure to determine how well the specialty pharmacy is helping the patient, Tancredi noted, as well as accurate and timely data collection. *The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc.
Просмотров: 630 Specialty Pharmacy Times
In-Office Dispensing of Oral Oncolytics
 
03:31
Steven L. D’Amato, RPh, BSPharm; Arturo Loaiza-Bonilla, MD, MSEd, FACP; Noa Biran, MD; Carl T. Henningson, MD; and Peter L. Salgo, MD, review the advantages of in-office dispensing of oral oncolytics.
Просмотров: 72 Specialty Pharmacy Times
Hepatitis C Patient Journey: A Miracle Cure for HCV
 
03:11
In part five, Jim Wilson, RPh, MBA, president of WilsonRx, discusses how his hepatitis C was cured through a clinical trial. Wilson was infected with an acute case of Non-A/Non-B hepatitis in 1975 due to a tainted blood supply but was not diagnosed with the disease until 1999. After receiving a liver transplant in 2006, he was finally cured of HCV in 2012 after enrolling in a 12-week clinical trial of the drug Harvoni.
Просмотров: 233 Specialty Pharmacy Times
Sovaldi Inventor Sounds Off on High Drug Cost Controversy
 
01:42
Michael Sofia, PhD, the inventor of the groundbreaking hepatitis C drug sofosbuvir (Sovaldi), discusses the issues of high drug pricing and the cost of innovation.
Просмотров: 794 Specialty Pharmacy Times
How Can Independent Specialty Pharmacies Best Manage DIR Fees?
 
01:30
Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the impact of direct and indirect remuneration fees on specialty pharmacy.
Просмотров: 109 Specialty Pharmacy Times
The Characteristics of Merck's Promising New Hepatitis C Drug
 
03:22
Janice Wahl, MD, Executive Director of Infectious Diseases at Merck Research Laboratories, discusses the benefits of the grazoprevir/elbasvir HCV drug combination.
Просмотров: 515 Specialty Pharmacy Times
What Are the Benefits, Challenges of Operating a Specialty Pharmacy Linked to a Retail Giant?
 
01:38
Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, discusses how operating a specialty pharmacy associated with a retail pharmacy can be beneficial.
Просмотров: 212 Specialty Pharmacy Times
Management of High Cost Medications
 
06:00
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss how to manage the high costs of specialty medications currently flooding the market. Prior authorization is a utilization management tool payors can use to control spending, Rayberg said, as well as ensuring a proper diagnosis and preventing off-label use of medication. Allen explained in detail how split-fill programs can benefit payors, not only by preventing the waste of high-cost medications, but also because it means there will be more frequent live touch points to follow up with the patient. Adequately educating the patient about how a split-fill program works can also be beneficial, Ness added. This split-fill strategy can also help keep medication costs at long-term care facilities down, Karalis said. In addition, nonbiased programs that do not base formulary decisions on reimbursement challenges and instead focus just on the appropriate patient care will ultimately produce the best outcomes, he concluded. *The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc.
Просмотров: 317 Specialty Pharmacy Times
What Type of Patient Metrics Can Data Aggregators Provide to Manufacturers, Specialty Pharmacies?
 
02:30
John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses data collection and analytics services that aggregators can offer manufacturers.
Просмотров: 41 Specialty Pharmacy Times
New Products and Limited Distribution Channels
 
08:31
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss the need for limited distribution, and developing trends moving forward. The panelists agreed that there is a place for limited distribution, such as for rare or orphan diseases, for products with complicated risk evaluation and mitigation strategy programs, or when detailed inventory reports are needed due to the costs of manufacturing. Karalis predicts that patient care could become increasingly complicated, especially in the oncology setting, where there is the potential for a single patient to be prescribed more than one medicine that is in limited distribution, which may mean having to deal with multiple specialty pharmacies at a time. Allen noted that specialty pharmacies, as providers of these limited distribution products, may be able to facilitate the integration of the different players involved in the patient’s treatment network. Ness, however, pointed out that not all specialty pharmacies excel at this task. Tancredi added that there will continue to be limited distribution until new products for orphan diseases or cancer can be handled uniformly throughout the continuum of pharmacies. *The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc.
Просмотров: 236 Specialty Pharmacy Times
Rheumatoid Arthritis Treatment Guidelines
 
02:09
Cheryl Allen, BS Pharm, MBA, outlines the different rheumatoid arthritis treatment guidelines.
Просмотров: 130 Specialty Pharmacy Times
Improving Drug Utilization Management
 
01:11
Raulo Frear, PharmD, general manager of OmedaRx, discusses methods to enhance management of drug utilization programs.
Просмотров: 200 Specialty Pharmacy Times
The Benefits of Pharmacy Accreditation
 
01:54
Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses what comprises an effective pharmacy accreditation program.
Просмотров: 130 Specialty Pharmacy Times
Developing Trends in Specialty Pharmacy Contracting
 
01:28
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses developments in contracting that specialty pharmacies need to be aware of.
Просмотров: 119 Specialty Pharmacy Times
ACO Growth Impact on Specialty Pharmacy
 
01:20
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses the impact of Accountable Care Organizations on specialty pharmacy.
Просмотров: 116 Specialty Pharmacy Times
Hepatitis C Virus: Achieving an SVR and Unmet Patient Needs
 
07:33
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss the challenges in reducing hepatitis C to a rare disease and unmet patient needs in both hepatitis C and oncology. While the eradication of hepatitis C is a laudable goal, Ness said that achieving this would be difficult due to millions of patients who remain undiagnosed, which raises the need of improved screening methods. Karalis noted that importance of vaccination, stating that patients receiving treatment at specialty pharmacies need to have received immunization for hepatitis A and B to mitigate the spread of the disease while their being cured. From the perspective of specialty pharmacies, Allen indicated that unmet patient needs persist within the channel that require support programs, including copay assistance, funding assistance, and compliance support. In terms of providing support for unmet needs in the oncology space, Karalis said taking care of the whole patient, including the proper management of comorbidities, is vital to the success of a therapy. Ness added that outcomes data, including progression free survival and overall survival, reported in a useable manner to make value decisions is a pressing unmet need in the oncology space. *The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc.
Просмотров: 400 Specialty Pharmacy Times
Leveraging Data Analytics in Specialty Pharmacy
 
01:26
Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can best utilize data to improve patient outcomes.
Просмотров: 47 Specialty Pharmacy Times
How Can Specialty Pharmacy Benefit from Copay Assistance Programs?
 
01:56
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses copay and reimbursement assistance programs.
Просмотров: 95 Specialty Pharmacy Times
How Can Care Coordination Improve Care for Patients Taking Specialty Drugs?
 
00:49
Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, talks about the importance of care coordination.
Просмотров: 138 Specialty Pharmacy Times
What Strategies Should Specialty Pharmacies Use to Ensure Patient Satisfaction?
 
01:15
Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the best strategies to ensure patient satisfaction.
Просмотров: 47 Specialty Pharmacy Times